Ongoing Research And Development By Key Players To Foster The Growth Of The Adrenoleukodystrophy Drugs Market
Adrenoleukodystrophy, sometimes called adrenal dysfunction or adrenal hyperplasia, is a serious genetic disorder that causes the accumulation of long, skinny chain fatty acids (VLDFAs) in your brain. When VLDFas stack up over the critical myelin sheaths surrounding nerve fibers, they cause devastating damage to the brain. This may lead to impairments in learning and memory, sensory perception, endocrine system, cardiovascular system, muscular system, and immunity. It is estimated that approximately 1 million Americans suffer from this debilitating condition. Several genes are involved in the development of adrenoleukodystrophy, including the genes encoding the protein receptor cells that respond to VLDFas. Some people with a form of this disease have a mutation at the receptor gene that inhibits the activity of VLDFas, leaving the receptors unresponsive to insulin and therefore not responding to the growth hormone. The other type of Adrenoleukodystrophy develops when someone has a...